Lv3
350 积分 2022-05-17 加入
Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
1天前
求助中
Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
1天前
已完结
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
1天前
已完结
Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
1天前
已完结
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
3天前
已完结
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
3天前
已完结
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
4天前
已完结
The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study*
4天前
已完结
Reductions in World Health Organization Risk Drinking Levels as a Primary Efficacy End Point for Alcohol Clinical Trials
1个月前
已关闭
Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study
1个月前
已完结
皖公网安备34019202002308
